Patent · US Active

Polymorphic forms of deferasirox (ICL670A)

US8153672B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

Novartis AG · CH

Inventor

Michael Mutz · Glückstadt, DE

Key dates

Filing date	Nov 27, 2007
Grant date	Apr 10, 2012
Priority date	—
Expiry date	Apr 3, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.